Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Biotechnology Average - - - - - - 14,038.94 840.80 209.33 -193.00 36.68 0.00 19.1210 -0.31 -0.8992 -10.2613 -0.09 -0.08 7.2452 - -
Maximum - - - - - - 465,034.00 65,349.00 25,407.00 99,050.00 5,305.00 0.01 1,336.3467 6.70 3.0051 85.3485 0.38 8.35 61.5621 - -
Minimum - - - - - - 0.00 0.00 -1,175.00 -56,335.00 -1,185.00 0.00 -164.8536 -8.99 -101.7758 -267.9821 -1.56 -12.64 0.0007 - -
Nuvalent, Inc. NUVL 90.99 -3.40 -3.60% 350 vs. 512 6,350.00 0.00 -44.00 -36.00 -330.00 -0.6900 -27.7942 0.0000 0.0000 0.0000 -0.0659 -0.0628 20.6970 69.00
DICE Therapeutics, Inc. DICE 47.55 0.03 0.06% 4,332 vs. 1,753 2,270.00 0.00 -34.00 -30.00 -248.00 -0.7400 -15.7831 0.0000 0.0000 0.0000 -0.0671 -0.0632 25.6858 47.00
Vaxcyte, Inc. PCVX 99.38 -4.26 -4.11% 1,508 vs. 973 12,386.00 0.00 -95.00 -171.00 -1,019.00 -0.8500 -19.6094 0.0000 0.0000 0.0000 -0.0479 -0.0454 17.2498 124.00
Prothena Corporation plc PRTA 17.36 -0.72 -3.98% 361 vs. 463 933.00 0.00 -72.00 -73.00 -1,052.00 -1.3400 -4.8610 0.0000 -16.7400 -1444.7800 -0.1438 -0.1159 12.6314 53.00
Madrigal Pharmaceuticals, Inc. MDGL 339.04 -0.62 -0.18% 367 vs. 347 7,394.00 0.00 -147.00 -149.00 -1,483.00 -7.3800 -8.6674 0.0000 0.0000 0.0000 -0.1734 -0.1363 9.2623 21.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for PRTA and its peers to uncover potential buy and sell opportunities.